Answers are grounded in this paper and cite their sources.
The need for new "pull" incentives to stimulate antibiotic R&D is widely recognized. Due to the global diversity of health systems, combined with different challenges faced by antibiotics used in different types of healthcare settings, there is no one-size-fits-all solution. Instead, different "pull" incentives should be tailored to local contexts, priorities, and antibiotic types. Policymakers and industry should collaborate to identify appropriate solutions at the local, regional, and global levels.
No takes yet. Share an insight, caveat, or question.
Bhatti et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: